Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: followup after a mean of 13.3 years

Arthritis Rheum. 1997 May;40(5):984-5. doi: 10.1002/art.1780400533.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / mortality*
  • Cohort Studies
  • Humans
  • Methotrexate / therapeutic use*
  • Methotrexate / toxicity
  • Middle Aged
  • Prospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Methotrexate